SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as community sentiment balances between bullish technical setups and cautious skepticism regarding its long-term utility. Traders are actively debating potential breakout levels while watching for broader market momentum to influence the coin's next move.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate into Japanese blockchain projects and IoT-focused tokens. While community members are polarized between long-term accumulation and skepticism regarding project leadership and ecosystem expansion, active discussions remain centered on potential technical breakout patterns and broader data economy narratives.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy community is actively attempting to revitalize interest in their crypto token, frequently citing its past market cap highs and the potential for a new parabolic rally. While proponents encourage buyers to hold through volatility and rotate profits from other assets, skeptics continue to warn of historical pump-and-dump patterns and the token's lack of fundamental utility.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing increased community engagement as traders speculate on its price trajectory and potential for a breakout, often drawing comparisons to other speculative assets. The conversation is heavily driven by its active social media presence, with proponents highlighting its status as a meme coin and its frequent inclusion in broader crypto trend discussions.

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

TransCode Therapeutics Inc

TransCode Therapeutics is currently seeing intense activity following a strategic acquisition of Polynoma and a significant equity infusion, which investors are weighing against concerns regarding dilution and the company's past history of reverse splits. Community discussion is heavily focused on whether this financing provides the necessary runway for their metastatic cancer drug, TTX-MC138, to finally demonstrate efficacy in upcoming Phase 2 trials.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).   The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.  The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

Bio Protocol

Bio Protocol is capturing attention following its recent listing on Coinbase and excitement surrounding its V2 upgrade, which includes new staking rewards. Community sentiment is highly bullish as investors draw comparisons to other high-momentum tokens, actively debating potential price breakouts and the long-term potential of the DeSci sector.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community debates its long-term potential and utility amidst a challenging price environment. While some investors express frustration over recent performance, others are actively accumulating tokens, holding onto the belief that the project will eventually see a significant recovery.

A community-driven memecoin created to protect and empower crypto users, CTOs, and low-marketcap gems. Our ecosystem features weekly crypto talks/hosting services, a “Most Wanted" scam tracker, and a "Portfolio" with partnered projects. We help others succeed through long-term partnerships and services.   Weekly Hosting: a weekly hosting service where the team and community come together to talk about crypto and project updates. We will invite guests from rugged projects who want to talk/share insight, invite CTO/low market cap projects to come speak about what they are doing, and give dedicated time for partnered projects to speak on updates for our listeners.   Portfolio: webpage highlighting CTOs, low market cap gems, and strong founding teams. Projects must meet internal standards: long-term vision, accountable/transparent  leadership, real utility or original design, fair incentives, and consistent execution.  Commitment Mechanism: Projects signal alignment with $RCON’s values by voluntarily burning $RCON, demonstrating long-term conviction and shared responsibility. The Marketcap of $RCON dictates burn tiers for each new project.  &lt; 250k Marketcap - variable at team discretion 250k - 500k Marketcap - $1,000 USD 500k - 1M Marketcap - $1,500 USD 1M - 2.5M Marketcap - $2,000 USD 2.5M - 5M Marketcap - $3,000 USD 5M - 10M Marketcap - $4,000 USD 10M+ Marketcap - $5,000 USD  Most Wanted: A webpage highlighting community-reported concerns, risk indicators, and educational insights related to suspected scams, exploits, or high-risk crypto activity. Content is aggregated from public posts using hashtag #RRMW (Recon Raccoon’s Most Wanted) on X and reflects community observations and opinions for informational purposes only. Inclusion does not imply wrongdoing. Users should independently verify all information.

Recon Raccoon

Recon Raccoon is gaining traction behind a series of exchange listings and ongoing marketing campaigns designed to expand its visibility within the Solana ecosystem. The community is actively discussing the project's long-term infrastructure, including new liquidity pools and strategic partnerships intended to drive sustainable growth.

Brinker International, Inc. engages in owning, developing, and franchising Chili's Grill and Bar and Maggiano's Little Italy restaurant brands. It operates through the Chili's and Maggiano's segments. The Chili's segment includes the results of company-owned Chili's restaurants in the U.S. and Canada as well as the results from its domestic and international franchise business. The Maggiano's segment refers to the results of company owned Maggiano's restaurants. The company was founded by Larry Lavine on March 13, 1975 and is headquartered in Dallas, TX.

Brinker International, Inc.

Brinker International, Inc. (EAT) has emerged as a standout performer in the restaurant sector, with investors pointing to robust same-store sales growth, traffic gains at Chili's, and successful menu innovation as key drivers behind the stock's recent momentum. The community is actively discussing the company's operational execution and its ability to maintain value-oriented appeal, though some participants remain cautious, debating the sustainability of current valuation levels and potential macro headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now?

Key PointsLast month, Roth Capital's William Kirk upgraded Tilray Brands shares from "neutral" to "buy," raising his price target to $10 per share...

Tilray Brands, Inc. (TLRY) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Tilray Brands (TLRY). This makes it worthwhile to examine what the stock has in store.

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.2% - Time to Buy?

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.2% - Should You Buy...

Should SNDL Stock Be in Your Portfolio Post Q1 Earnings?

SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.

<ul class="summary-bullets"><li>BrewDog, now owned by Tilray, announced a 12-month partnership covering major U.K. festivals.</li><li>Tilray has recently rolled out several beverage-focused announcements, including new ready-to-drink products from 10 Barrel Brewing.</li><li>Investor frustration comes despite improving U.S. cannabis policy momentum after marijuana was moved from Schedule I to Schedule III for regulated medical use last month.</li></ul>Shares of Tilray Brands, Inc. (TLRY) slid to an over nine-month low on Tuesday after another beer-focused announcement fueled retail concerns that the company is becoming more of a brewery than a cannabis player.<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> fell 4% on Tuesday to $5.69, logging its third straight session of losses. It is also the second-worst performer so far this year among major cannabis stocks, with shares down 37%.&nbsp;<h2 class="st-heading-2">Beer Buzz, Cannabis Blues</h2>The latest pressure came after BrewDog, now owned by Tilray, announced a 12-month partnership with Underbelly covering major U.K. festivals and venues, including the Edinburgh Fringe Festival, London’s Underbelly Boulevard Soho and holiday events in Trafalgar Square and Leicester Square.The announcement added to a string of beverage-focused headlines from Tilray over the past few weeks. Earlier this month, Tilray-owned 10 Barrel Brewing launched new ready-to-drink beverages called “Clean Slate” and “Salty Sips,” while SweetWater Brewing unveiled a new “Livin’ Salty” lager collaboration with Salt Life.The flow of brewery, beer and beverage announcements has frustrated cannabis-focused investors, particularly after the U.S. government moved marijuana from Schedule I to Schedule III for regulated medical use last month. The policy change was widely viewed as one of the most important federal cannabis reforms in decades and sparked optimism across pot stocks.<h2 class="st-heading-2">Tilray's US Pot Push Still On Hold</h2>After the U.S. rescheduling announcement, Tilray aggressively positioned itself as a major player in the cannabis market. CEO Irwin Simon said at the time that “federal policy is finally aligning with science, medicine, and most importantly, patient needs,” while calling the policy change a “defining inflection point” for medical cannabis in the U.S.In a later Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=fn5xb8RPLPM">interview</a>, Simon said Tilray was “one of the largest cannabis companies in the world” with over 7 million square feet of cultivation capacity and cannabis operations spanning more than 21 countries.However, Simon also acknowledged that Tilray currently has no U.S. cannabis operations involving THC, the compound in marijuana responsible for the “high” associated with cannabis use. “Tilray today cannot sell any cannabis in the U.S.,” he said, adding that the company instead chose “a different fork in the road” by expanding into beer, beverages and wellness businesses while waiting for federal cannabis reform.Simon said Tilray has already developed the “playbook,” genetics and medical research to move quickly into the U.S. cannabis market if regulations advance further. “Could we be in a business within six months? Absolutely, if we get the right approvals,” he said.<h2 class="st-heading-2">Tilray Says It’s ‘Not A Little Craft Brewer’</h2>Tilray’s beverage focus accelerated after the company completed its acquisition of key BrewDog assets in March, including the global brand, U.K. brewing operations, and brewpub portfolio. Tilray said the deal would help build a global beverage platform generating $500 million in annual revenue.During the company’s most recent earnings call, Simon stressed the importance of BrewDog and the broader beverage business. “I've done over 100 acquisitions in my life, and I've never received more calls, congratulations, and a brand with more awareness on a global basis, which helps Tilray to be at the forefront around the world,” Simon said while discussing BrewDog.He also said Tilray is “not just a little craft brewer anymore” as the company scales toward nearly 18 million beer cases globally. The company said that, after the BrewDog transaction, Tilray is now the fourth-largest craft brewer in the U.S. and the top craft brewer in the U.K. Simon said Tilray is evolving into a “global lifestyle consumer products company” spanning beverages, cannabis and wellness products across over 20 countries.<h2 class="st-heading-2">How Do Retail Traders Feel About TLRY?</h2>On Stocktwits, retail sentiment for TLRY hovered around record low levels (21/100) at ‘extremely bullish’ levels amid nearly a 600% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/tlry_ss_png_7d1d173bf2.webp" alt="tlry ss.png" width="966" height="146"><figcaption>TLRY sentiment and message volume as of May 6 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Alexsolstice/message/652324536">said</a> TLRY “completely missed to prepare for US rescheduling opportunities - no US licensed assets, no net cash. Mostly dilution and lawsuits.”&nbsp;<stembedurl>https://stocktwits.com/Alexsolstice/message/652324536</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/smooth2222/message/652300863">said</a>, “PR your Cannabis plans, stop with the beverage PR’s,” while a separate trader&nbsp;<a href="https://stocktwits.com/knocker/message/652229091">said</a>, “ individuals are holding a stock that was marketed as a 'Quantum Leap' for cannabis but has settled into being a German Pill Distributor that owns a Mid-Tier Craft Brewery conglomerate.”<stembedurl>https://stocktwits.com/knocker/message/652229091</stembedurl>TLRY stock has risen 29% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amc-stock-soars-on-record-post-pandemic-box-office-outlook/cZQyr18ReaE">AMC Stock Soars On Box Office Comeback: CEO Bullish On ‘Record Post-Pandemic’ Year&nbsp;</a>

In this photo illustration, the logo of a Canadian pharmaceutical and cannabis company, Tilray, is seen on a smartphone and a PC screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tilray Stock's High Is Fading — Cannabis Bulls Aren't Buzzing Over The Beer Pivot

CEO Irwin Simon said that the company currently has no U.S. THC cannabis operations and chose “a different fork in the road” by expanding into beverages.

Equity

Tilray Brands (NASDAQ:TLRY)  Shares Down 3.6%   - Here's Why

Tilray Brands (NASDAQ:TLRY) Trading Down 3.6% - Here's What Happened...

Cannabis Stocks To Watch Now - May 5th

Tilray Brands, Akanda, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies that participate in the cannabis industry, including cultivators, processors, distributors, retailers, and an...

Tilray Brands (NASDAQ:TLRY) Stock Price Down 4.2%  - Should You Sell?

Tilray Brands (NASDAQ:TLRY) Trading Down 4.2% - Should You Sell...

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

Key PointsTilray Brands believes it's in a great position to take advantage of opportunities in a regulated medical marijuana market in the U.S...

Tilray Brands (NASDAQ:TLRY) Stock Price Down 1.3% - Here's Why

Tilray Brands (NASDAQ:TLRY) Shares Down 1.3% - Here's Why...

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Stocktwits

Stocktwits Polls

Retail investors are expressing intense frustration with leadership, demanding the removal of the current CEO citing years of share price decline and dilution.

Traders are closely watching for potential short-squeeze setups as bullish investors bet on a sector-wide reversal against high levels of bearish sentiment.

The community is fixated on DEA rescheduling developments and potential legislative changes as key catalysts for long-term valuation shifts.

Frequent debates are surfacing about whether current support levels represent a definitive bottom or if the stock is trapped in a multi-year decline.

Discussions highlight the company's diversification into craft beer and THC beverages as both a strategic branding effort and a point of controversy for shareholders.

TLRY
Tilray Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest TLRY News

TLRYTilray Brands Inc